论文部分内容阅读
目的观察防哮膏治疗儿童哮喘缓解期的临床疗效。方法 40例哮喘缓解期患儿随机分为治疗组和对照组,每组20例。治疗组给予防哮膏口服,对照组给予辅舒酮吸入,观察2组患儿用药前后症状、体征、哮喘发作次数、感冒次数变化及免疫系统的改善状况。结果治疗组总有效率为90.00%,对照组为85.00%,2组比较差异无统计意义(P>0.05);治疗组在改善自汗、神疲懒言、面色等症状方面优于对照组,2组比较差异有统计意义(P<0.05);治疗组在减轻哮喘发作次数方面与对照组疗效相当,差异无统计意义(P>0.05);治疗组在减少感冒次数方面明显优于对照组,2组比较差异有高度统计意义(P<0.01);治疗组在提高患儿免疫球蛋白A(Ig A)、免疫球蛋白G(Ig G)、免疫球蛋白M(Ig M)水平方面明显优于对照组,2组比较差异有高度统计意义(P<0.01)。结论防哮膏可有效改善患儿体质状态、提高免疫力、预防感冒及哮喘发作,达到控制哮喘的目的,值得临床推广。
Objective To observe the clinical efficacy of anti-asthma cream in the treatment of childhood asthma remission. Methods Forty cases of asthma remission children were randomly divided into treatment group and control group, 20 cases in each group. The treatment group was given oral anti-asthmatic cream, and the control group was given Fu-Shu ketone inhalation. The symptoms and signs, the number of asthma attacks, the frequency of cold and the improvement of the immune system were observed before and after treatment in both groups. Results The total effective rate was 90.00% in the treatment group and 85.00% in the control group, with no significant difference between the two groups (P> 0.05). The treatment group was better than the control group in improving symptoms such as spontaneous perspiration, The difference between the two groups was statistically significant (P <0.05); treatment group in the reduction of the number of asthma attacks with the efficacy of the control group was comparable, the difference was not statistically significant (P> 0.05); treatment group was significantly better than the control group in reducing the frequency of cold, The difference between the two groups was statistically significant (P <0.01). The treatment group was significantly superior in improving the levels of Ig A, Ig G and Ig M in children In the control group, the difference between the two groups was highly statistically significant (P <0.01). Conclusion Anti-asthmatic cream can effectively improve children’s physical condition, improve immunity, prevent colds and asthma attacks, to achieve the purpose of controlling asthma, worthy of clinical promotion.